PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.06
0.06 - 0.24
2.78M / 3.59M (Avg.)
-1.55 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.58%
Negative revenue growth while YAL.AX stands at 16.36%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
46.64%
Gross profit growth above 1.5x YAL.AX's 24.80%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
191.76%
EBIT growth above 1.5x YAL.AX's 106.33%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
90.24%
Positive operating income growth while YAL.AX is negative. John Neff might view this as a competitive edge in operations.
153.85%
Net income growth above 1.5x YAL.AX's 89.52%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
154.17%
EPS growth above 1.5x YAL.AX's 87.50%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
154.17%
Diluted EPS growth above 1.5x YAL.AX's 87.50%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.57%
Share reduction while YAL.AX is at 0.32%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.57%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
169.21%
OCF growth above 1.5x YAL.AX's 51.59%. David Dodd would confirm a clear edge in underlying cash generation.
133.22%
FCF growth above 1.5x YAL.AX's 54.96%. David Dodd would verify if the firm’s strategic investments yield superior returns.
No Data
No Data available this quarter, please select a different quarter.
-56.59%
Negative 5Y CAGR while YAL.AX stands at 70.47%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-72.78%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
117.39%
10Y OCF/share CAGR in line with YAL.AX's 117.97%. Walter Schloss would see both as similarly efficient over the decade.
144.23%
5Y OCF/share CAGR above 1.5x YAL.AX's 67.53%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-87.51%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
101.21%
Similar net income/share CAGR to YAL.AX's 110.16%. Walter Schloss would see parallel tailwinds or expansions for both firms.
119.90%
Below 50% of YAL.AX's 413.54%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-94.42%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-55.05%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
62.39%
5Y equity/share CAGR 1.25-1.5x YAL.AX's 51.19%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
525.13%
3Y equity/share CAGR above 1.5x YAL.AX's 51.61%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
2.37%
Stable or rising mid-term dividends while YAL.AX is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Firm’s AR is declining while YAL.AX shows 22.45%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
82.91%
We show growth while YAL.AX is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-5.14%
Negative asset growth while YAL.AX invests at 11.01%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.07%
We have a declining book value while YAL.AX shows 10.04%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-2.47%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
12.63%
SG&A declining or stable vs. YAL.AX's 109.93%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.